Review of draft FDA adaptive design guidance.

Review of draft FDA adaptive design guidance.

Item
http://www.wikidata.org/entity/Q37807934
Adaptive designs undertaken in clinical research: a review of registered clinical trialsMissing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials.Adding a treatment arm to an ongoing clinical trial: a review of methodology and practiceAdaptive design of confirmatory trials: Advances and challenges.Improved design of prodromal Alzheimer's disease trials through cohort enrichment and surrogate endpointsSystems pharmacology, pharmacogenetics, and clinical trial design in network medicineClinical Trial Principles and Endpoint Definitions for Paravalvular Leaks in Surgical Prosthesis: An Expert Statement.Developing methodology for the creation of clinical practice guidelines for rare diseases: A report from RARE-Bestpractices.The Real-World Ethics of Adaptive-Design Clinical Trials.Comparing three regularization methods to avoid extreme allocation probability in response-adaptive randomization.
P2860

Review of draft FDA adaptive design guidance.

Item
http://www.wikidata.org/entity/Q37807934
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Review of draft FDA adaptive design guidance.
@en
Review of draft FDA adaptive design guidance.
@nl
type
label
Review of draft FDA adaptive design guidance.
@en
Review of draft FDA adaptive design guidance.
@nl
prefLabel
Review of draft FDA adaptive design guidance.
@en
Review of draft FDA adaptive design guidance.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Review of draft FDA adaptive design guidance.
@en
P2093
P2860
P304
P31
P356
10.1080/10543406.2010.514455
P433
P478
P577
P698